MediGene awarded Euro 600,000 research grant

Published: 11-Feb-2008

German biotech company MediGene is to receive a research grant totalling approximately Euro 600,000 (


German biotech company MediGene is to receive a research grant totalling approximately Euro 600,000 (£447,610) over three years from the Federal Ministry of Education and Research (BMBF) under the funding programme KMU-innovativ: Biotechnologie - BioChance.

The "BioChancePlus" competition aims to boost the innovation potential of small and medium-sized enterprises in the field of top-level research. Another purpose of the funding programme is to strengthen the technological foundation of biotech companies to provide a basis for their sustained growth.

"We are proud that our research project was chosen for this renowned funding programme by an independent academic committee. This underlines our company's expertise in research," said Dr Peter Heinrich, ceo of MediGene, adding that government funding of innovative research and development activities is a very important and positive signal for the German biotech sector.

You may also like